P&G targeting Pfizer’s Consumer Health arm

CNBC yesterday afternoon reported that the US giant Procter & Gamble is in talks with Pfizer to acquire the company’s Consumer Health arm. P&G, in fact, is the only potential buyer left, after Reckitt Benckiser and GlaxoSmithKline have announced they would renounce to continue talks with Pfizer. According to the US channel, P&G has valued the asset $15bn, while Pfizer seeks to raise at least  $20bn.

(Source: CNBC)